Studying Health Outcomes After Treatment in Patients With Retinoblastoma
Recruiting now
Conditions studied: Retinoblastoma, Cancer Survivor, Biological Sibling, Intraocular Retinoblastoma, Unilateral Retinoblastoma
In brief
This trial studies health outcomes after treatment in patients with retinoblastoma. Gathering health information over time from patients and family members through vision assessments, samples of tissue and saliva, and questionnaires may help doctors learn more about what causes retinoblastoma, identify long-term health outcomes for patients with retinoblastoma, and find out which therapies may be the best for treating retinoblastoma
Key facts
- Study ID
- NCT03932786
- Run by
- Vanderbilt-Ingram Cancer Center
- People needed
- 900
- Starts
- 2019-01-24
- Expected to finish
- 2031-01-01
- Last updated by the study team
- 2025-09-19
Who can join
Age: any. Sex: any. Healthy volunteers: accepted.
Where it is running
- Lurie Children's Hospital — Chicago, Illinois, United States (enrolling)
- University of Illinois, Chicago — Chicago, Illinois, United States (enrolling)
- University of Minnesoa — Minneapolis, Minnesota, United States (enrolling)
- Washington School of Medicine at St. Louis — St Louis, Missouri, United States (enrolling)
- Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio, United States (enrolling)
- Children's Hospital of Philadelphia — Philadelphia, Pennsylvania, United States (enrolling)
- Vanderbilt-Ingram Cancer Center — Nashville, Tennessee, United States (enrolling)
- MD Anderson Cancer Center — Houston, Texas, United States (enrolling)
- Texas Childeren's Hospital — Houston, Texas, United States (enrolling)
- Children's Hospital of Wisconsin — Milwaukee, Wisconsin, United States (enrolling)
- The Hosptial for Sick Children — Toronto, Canada (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.